NanoViricides is leveraging its unique nanoviricide platform technology to create first-in-class drugs against viruses
NanoViricides is leveraging its unique nanoviricide platform tech…
Jun 21, 2023
proactiveinvestors.com
NanoViricides advances antiviral drug with Phase II Clinical trial to Combat MPox
NanoViricides advances antiviral drug with Phase II Clinical trial to …
Jan 28, 2025
proactiveinvestors.com
NanoViricides using unique technology platform to fight against Viruses
NanoViricides using unique technology platform to fight again…
Apr 11, 2023
proactiveinvestors.com
NanoViricides CEO discusses progress of broad-spectrum antiviral candidate NV-387 - ICYMI
NanoViricides CEO discusses progress of broad-spectrum antivi…
3 months ago
proactiveinvestors.com
WHO Extended Global Emergency Status of MPox Epidemic - Development of Treatment for MPox with NV-387 is Timely, Says NanoViricides
WHO Extended Global Emergency Status of MPox Epidemic - Develo…
10 months ago
finanznachrichten.de
NanoViricides CEO discusses NV-387’s broad-spectrum antiviral potential
NanoViricides CEO discusses NV-387’s broad-spectrum antiviral pot…
May 13, 2024
proactiveinvestors.com
NanoViricides: Measles Cases Are Increasing Globally; MPox Continues to Be a Threat - Broad-Spectrum Antiviral Drug Could Be the Solution
NanoViricides: Measles Cases Are Increasing Globally; MPox Contin…
May 14, 2025
finanznachrichten.de
NanoViricides seeks FDA’s rare pediatric disease designation for a…
1 month ago
proactiveinvestors.com
NanoViricides unaffected by US tariff turmoil, says CFO
Apr 4, 2025
proactiveinvestors.com
NanoViricides advances toward fully funded Phase II MPox trial in DRC
3 months ago
proactiveinvestors.com
Nanoviricides, Inc. NanoViricides Inc. annonce que son nanoviricide…
Jun 11, 2024
zonebourse.com
9:39
NanoViricides advances toward fully funded Phase II MPox trial in DRC
3 months ago
YahooProactive
0:33
NanoViricides: New antiviral shows incredible results safety & effectiv…
151 views7 months ago
YouTubeProactive Investors
NanoViricides’ NV-387 shows potent anti-measles activity, highlighting …
7 months ago
proactiveinvestors.com
3:56
Innovations and Recognitions in the Healthcare Industry: Updates fro…
6 views4 months ago
YouTubeNewsRamp
7:18
NanoViricides take big step forward beginning trials on its Antiviral Dr…
2.2K viewsJun 29, 2023
YouTubeProactive Investors
Nanoviricides says NV-387 shows activity against measles virus in h…
7 months ago
marketscreener.com
0:57
NNVC: NanoViricides Set to Initiate Phase 2 Trial in MPox
60 views10 months ago
YouTubeZacks Investment Awareness
NanoViricides unimpacted by tariffs; sees boost by changes at govern…
Apr 4, 2025
proactiveinvestors.com
NanoViricides to attend D Boral Capital Conference
2 weeks ago
proactiveinvestors.co.uk
NanoViricides files for Rare Pediatric Disease Designation for …
1 month ago
proactiveinvestors.com
5:21
NanoViricides files for Rare Pediatric Disease Designation for …
1 month ago
YahooProactive
1:08
$NNVC Reports Their Broad-Spectrum Antiviral Drugs Human …
4 viewsAug 30, 2023
DailymotionBenzinga
1:29
NanoViricides Announces That Clinical Trials Of A Broad-Spectru…
1 viewsJul 6, 2023
DailymotionBenzinga
NanoViricides shares gain as new data shows lead drug asset's stro…
May 14, 2024
proactiveinvestors.com
Nanoviricides Co's Business Not Affected By Tariff Policies Of Us G…
Mar 11, 2025
marketscreener.com
NanoViricides: Fiscal Q3 Earnings Snapshot
1 week ago
kgw.comAssociated Press
1:04
NNVC: Phase 2 Trial of NV-387 Antiviral for Mpox | NanoViricides
99 views6 months ago
YouTubeZacks Investment Awareness
1:49
NanoViricides Announces Clinical Trial Of Broad-Spectrum Antiviral …
1 viewsJul 19, 2023
DailymotionBenzinga
1:47
NanoViricides: New drug shows promise RSV, Measles, Flu & COVID
205 views7 months ago
YouTubeProactive Investors
See more videos
Static thumbnail place holder